UK markets open in 58 minutes

Mirum Pharmaceuticals, Inc. (MIRM)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
24.02-0.40 (-1.64%)
At close: 04:00PM EDT
24.02 0.00 (0.00%)
After hours: 04:02PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
186,374
186,374
77,062
19,138
0
Cost of revenue
47,039
47,039
12,374
1,903
0
Gross profit
139,335
139,335
64,688
17,235
0
Operating expenses
Research development
102,609
102,609
106,842
131,428
81,605
Selling general and administrative
145,880
145,880
89,066
59,220
22,691
Total operating expenses
248,489
248,489
195,908
190,648
104,296
Operating income or loss
-109,154
-109,154
-131,220
-173,413
-104,296
Interest expense
15,105
15,105
15,979
17,590
335
Total other income/expenses net
-51,900
-51,900
1,271
106,686
-192
Income before tax
-162,424
-162,424
-142,071
-83,951
-103,264
Income tax expense
991
991
-6,406
37
6
Income from continuing operations
-163,415
-163,415
-135,665
-83,988
-103,270
Net income
-163,415
-163,415
-135,665
-83,988
-103,270
Net income available to common shareholders
-163,415
-163,415
-135,665
-83,988
-103,270
Basic EPS
-4.26
-4.00
-4.01
-2.77
-4.09
Diluted EPS
-4.27
-4.00
-4.02
-2.77
-4.09
Basic average shares
38,462
40,885
33,839
30,322
25,252
Diluted average shares
38,593
40,885
33,982
30,322
25,252